Researchers at the University of Nottingham‘s Centre for Additive Manufacturing (CfAM) in the UK received a £6 million ($7.4 million) grant from the British government to develop a toolkit that will allow 3D printed medicines to be manufactured more effectively. The project aims to create “smart products” on demand that are personalized and bespoke, driving innovations closer to commercial production. Examples include prosthetic limbs, bio drugs containing active ingredients like biological molecules, and living plasters or wound patches that can rebuild tissues damaged from chronic disease.